ENDRA Life Sciences News - NDRA

Company Name	Stock Ticker Symbol	Market	Type
ENDRA Life Sciences Inc	NDRA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0026	1.13%	0.2334	17:26:24

Open Price	Low Price	High Price	Close Price	Prev Close
0.237	0.2304	0.249	0.2334	0.2308

more quote information »

Recent News

Date	Time	Source	Heading
3/28/2024	16:05	BW	ENDRA Life Sciences Reports Fourth Quarter and Full Year..
3/21/2024	08:00	BW	ENDRA Life Sciences to Report Fourth Quarter 2023 Financial..
2/27/2024	08:00	BW	ENDRA Life Sciences Installs First TAEUS System in the UK
2/23/2024	17:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/21/2024	08:00	BW	New ICD-10-CM Code by the World Health Organization Paves..
2/14/2024	08:30	BW	ENDRA Life Sciences Bolsters TAEUS® System Intellectual..
12/29/2023	17:07	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/29/2023	08:00	BW	ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS®..
11/27/2023	08:00	BW	ENDRA Life Sciences to Participate in The Benchmark..
11/14/2023	16:05	BW	ENDRA Life Sciences Reports Third Quarter 2023 Financial..
11/14/2023	16:02	EDGAR2	Form 8-K - Current report
11/08/2023	08:00	BW	ENDRA Life Sciences Achieves Intellectual Property Milestone..
11/07/2023	16:05	BW	ENDRA Life Sciences to Report Third Quarter 2023 Financial..
11/06/2023	08:00	BW	ENDRA to Host Multidisciplinary Clinical Discussion on..
9/07/2023	08:00	BW	Abstract for ENDRA Life Sciences' TAEUS System Accepted for..
8/30/2023	08:00	BW	ENDRA Life Sciences' TAEUS De Novo Submission Advances to..
8/23/2023	08:00	BW	ENDRA Life Sciences Expands Intellectual Property with..
8/14/2023	16:45	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/2023	16:13	EDGAR2	Form 8-K - Current report
8/14/2023	16:05	BW	ENDRA Life Sciences Reports Second Quarter 2023 Financial..
8/14/2023	13:30	BW	ENDRA Life Sciences Submits De Novo Request for its TAEUS®..
8/10/2023	08:01	EDGAR2	Form 8-K - Current report
8/01/2023	08:00	BW	ENDRA Life Sciences to Report Second Quarter 2023 Financial..
7/25/2023	16:02	EDGAR2	Form 8-K - Current report
7/06/2023	17:25	EDGAR2	Form 8-K - Current report
7/06/2023	17:25	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
7/06/2023	16:45	BW	ENDRA Life Sciences Announces Adjournment of 2023 Annual..
6/07/2023	08:00	BW	Study Highlighting ENDRA Life Sciences’ TAEUS Technology to..
5/15/2023	16:05	BW	ENDRA Life Sciences Reports First Quarter 2023 Financial..
5/04/2023	08:00	BW	ENDRA Life Sciences to Report First Quarter 2023 Financial..
5/02/2023	16:01	BW	ENDRA Life Sciences Announces Closing of Public Offering and..
4/28/2023	08:00	BW	ENDRA Life Sciences Announces Pricing of Upsized $4.5..